Clinical Trial Details
EORTC-30955
Back to Clinical Trials Database
Phase III adjuvant trial:Interleukin-2, Interferon-alpha and 5-Fluorouracil for patients with high risk of relapse after surgical treatment for RCC
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 11-Feb-1998 Date Step1 close: 05-Jan-2004 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 550 |
| Treatment |
Surgery, Drug |
| Study Staff | |
| Type of cancer | Kidney |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00053807 |
| NCT number | NCT00053807 |
| Financial Support | Educational Grant |
